Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects

被引:213
作者
Moore, E
Wisniewski, A
Dobs, A
机构
[1] Johns Hopkins Univ Hosp, Div Endocrinol & Metab, Sch Med, Dept Med, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Pediat, Sch Med, Baltimore, MD 21287 USA
关键词
D O I
10.1210/jc.2002-021967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cross-sex hormone treatment is an important component in medical treatment of transsexual people. Endocrinologists are often faced with designing treatment recommendations. Although guidelines from organizations, such as the Harry Benjamin International Gender Dysphoria Association, have been helpful, management remains complex and experience guided. We discuss the range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment. Recommendations from seven clinical research centers treating transsexual people are discussed. In addition, self-reported hormonal regimens from 25 male-to-female transsexual people and five female-to-male transsexual people are reported. Finally, the potential adverse effects of cross-sex hormone treatment of transsexual people are reviewed. In light of the complexity of managing treatment goals and adverse effects, the active involvement of a medical doctor experienced in cross-sex hormonal therapy is vital to ensure the safety of transsexual people.
引用
收藏
页码:3467 / 3473
页数:7
相关论文
共 59 条
[11]  
COOPER M, 1983, HAWAII MED J, V43, P142
[12]   Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals [J].
Elbers, JMH ;
Asscheman, H ;
Seidell, JC ;
Frolich, M ;
Meinders, AE ;
Gooren, LJG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3267-3270
[13]   Long-term testosterone administration increases visceral fat in female to male transsexuals [J].
Elbers, JMH ;
Asscheman, H ;
Seidell, JC ;
Megens, JAJ ;
Gooren, LJG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2044-2047
[14]  
FUTTERWEIT W, 1980, NEW YORK STATE J MED, V80, P1260
[15]   ENDOCRINE EVALUATION OF 40 FEMALE-TO-MALE TRANSSEXUALS - INCREASED FREQUENCY OF POLYCYSTIC OVARIAN DISEASE IN FEMALE TRANSSEXUALISM [J].
FUTTERWEIT, W ;
WEISS, RA ;
FAGERSTROM, RM .
ARCHIVES OF SEXUAL BEHAVIOR, 1986, 15 (01) :69-78
[16]   Endocrine therapy of transsexualism and potential complications of long-term treatment [J].
Futterweit, W .
ARCHIVES OF SEXUAL BEHAVIOR, 1998, 27 (02) :209-226
[17]  
FUTTERWEIT W, 1988, MT SINAI J MED, V55, P309
[18]   HISTOPATHOLOGICAL EFFECTS OF EXOGENOUSLY ADMINISTERED TESTOSTERONE IN 19 FEMALE TO MALE-TRANSSEXUALS [J].
FUTTERWEIT, W ;
DELIGDISCH, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (01) :16-21
[19]  
FUTTERWEIT W, 1984, POLYCYSTIC OVARIAN D, P83
[20]   Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females [J].
Giltay, EJ ;
Gooren, LJG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2913-2921